Valeo Pharma (TSX:VPH) Total Inventories : C$9.71 Mil (As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Valeo Pharma Total Inventories?

Valeo Pharma's total inventories for the quarter that ended in Jan. 2024 was C$9.71 Mil. Valeo Pharma's average total inventories from the quarter that ended in Oct. 2023 to the quarter that ended in Jan. 2024 was C$9.98 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Valeo Pharma's Net-Net Working Capital per share for the quarter that ended in Jan. 2024 was C$-0.70.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Valeo Pharma's Days Inventory for the three months ended in Jan. 2024 was 80.69.

Inventory Turnover measures how fast the company turns over its inventory within a year. Valeo Pharma's Inventory Turnover for the quarter that ended in Jan. 2024 was 1.13.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Valeo Pharma's Inventory-to-Revenue for the quarter that ended in Jan. 2024 was 0.74.

Valeo Pharma Total Inventories Historical Data

The historical data trend for Valeo Pharma's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Total Inventories Chart

Valeo Pharma Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Total Inventories

Get a 7-Day Free Trial

0.56

0.88

7.68

9.98

10.25

Valeo Pharma Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Inventories	Get a 7-Day Free Trial															14.46	13.55	12.88	10.25	9.71

Valeo Pharma Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Valeo Pharma (TSX:VPH) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Valeo Pharma's Net-Net Working Capital Per Share for the quarter that ended in Jan. 2024 is

	Net-Net Working Capital Per Share (Q: Jan. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(9.585	+	0.75 * 4.875	+	0.5 * 9.705	-	87.366
-	0	-	0)	/	98.6669
=	-0.70

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Valeo Pharma's Days Inventory for the three months ended in Jan. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jan. 2024 )	/	Cost of Goods Sold (Q: Jan. 2024 )	*	Days in Period
	=	9.9755	/	11.281	*	365 / 4
	=	80.69

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Valeo Pharma's Inventory Turnover for the quarter that ended in Jan. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Jan. 2024 )	/	Average Total Inventories (Q: Jan. 2024 )
	=	11.281	/	9.9755
	=	1.13

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Valeo Pharma's Inventory to Revenue for the quarter that ended in Jan. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Jan. 2024 )	/	Revenue (Q: Jan. 2024 )
	=	9.9755	/	13.539
	=	0.74

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Valeo Pharma Total Inventories Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Valeo Pharma (TSX:VPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (TSX:VPH) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

VPHIF:USA

Address

16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9

Website

https://www.valeopharma.com

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Executives

Luc Mainville

Senior Officer

Valeo Pharma (TSX:VPH) Headlines

No Headlines